Estrogen Receptor Positive Breast Cancer Completed Phase 2 Trials for Aldesleukin (DB00041)

Also known as: Oestrogen receptor positive breast cancer

DBCOND0049177 (Estrogen Receptor Positive Breast Cancer)Completed2 IdentifierTitlePurposeDrugs
NCT00003199Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast CancerTreatment